The FDA love our safety profile, even if our product has the same efficacy or slightly worse it would still get to market and be the first line of treatment for doctors to treat young teenagers.
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway, page-82
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.020(4.94%) |
Mkt cap ! $698.4M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $3.442M | 8.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 26467 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 135324 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |